This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Otago Innovation Limited. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Christopher John Charles: Innovator in Cardiovascular Therapeutics
Introduction
Christopher John Charles is a notable inventor based in Christchurch, New Zealand. He has made significant contributions to the field of cardiovascular therapeutics, focusing on innovative solutions for treating cardiovascular diseases.
Latest Patents
Christopher holds a patent for "Cardiovascular therapeutics - Compounds and compositions comprising a B-type natriuretic signal peptide fragment agent, and methods of use thereof." This invention provides methods for the treatment or prevention of cardiovascular diseases, disorders, and conditions. He has 1 patent to his name.
Career Highlights
Throughout his career, Christopher has worked with various organizations, including Otago Innovation Limited and Upstream Medical Technologies Limited. His work has been instrumental in advancing therapeutic options for patients suffering from cardiovascular issues.
Collaborations
Christopher has collaborated with notable individuals in his field, including Christopher Joseph Pemberton and Arthur Mark Richards. These partnerships have contributed to the development of innovative solutions in cardiovascular health.
Conclusion
Christopher John Charles is a dedicated inventor whose work in cardiovascular therapeutics showcases his commitment to improving health outcomes. His innovative approaches continue to influence the medical field positively.